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Surprisingly, whereas for a long time Por2 was not considered to
have a channel activity [6], mitochondria from ΔPOR1 strain imported
signiﬁcant amount of tRK1 in presence of cytb2-DHFR. Experiments
with vesicles prepared from outer membrane of wild type and
ΔPOR1,2mitochondria conﬁrmed the essential role of Por2 protein in
tRK1 import. Finally, ﬁrst time isolated homogenous Por2 was
reconstituted into small unilamellar vesicles and planar phospholipid
bilayer membranes. With proteoliposomes it was shown that Por2
provides transport of carbohydrates and nucleotides across the
membrane with the same kinetic as for Por1 and on bilayer system
cation selective channels were registered with conductivity about
2 nS and closure with voltage above 30 mV in pH dependent manner.
Physiological role of Por2 and downregulation mechanism of its
channel activity in mitochondrial outer membrane are discussed.
An understanding of the ﬁne mechanisms of tRNA import from
cytosol could help us to improve delivery of “therapeutic” RNA
molecules into mitochondria to cure at themolecular level the negative
effects of mutations of tRNA genes coded by the mitochondrial DNA
causes large number of human diseases, such as Mitochondrial
Encephalomyopathy, Lactic Acidosis, and Stroke-like episodes (MELAS)
or Myoclonic Epilepsy with Ragged Red Fibers (MERRF) [7].
References
[1] R. Martin, J.M. Schneller, A. Stahl, G. Dirheimer, Biochemistry 18
(1979) 4600–4605.
[2] P. Kamenski, O. Kolesnikova, V. Jubenot, N. Entelis, I.
Krasheninnikov, R.P. Martin, I. Tarassov, Mol. Cell 26 (2007)
625–637.
[3] I. Tarassov, N. Entelis, et al., J. Mol. Biol. 245 (4) (1995) 315–323.
[4] N. Entelis, I. Brandina, et al., Genes Dev. 20 (12) (2006)
1609–1620.
[5] H. Koll, B. Guiard, J. Rassow, J. Ostermann, A.L. Horwich, W.
Neupert, F.U. Hart, Cell 68 (6) (1992) 1163–1175.
[6] A.C. Lee, X. Xu, E. Blachly-Dyson, M. Forte, M. Colombini, J.
Membr. Biol. 161 (1998) 173–181.
[7] D.C. Wallace, M.T. Lott, J.M. Shoffner, S. Ballinger, Epilepsia 35
(1994) S43–S50.
doi:10.1016/j.bbabio.2012.06.334
15P23
Activation of the p66Shc pathway in mitochondria-related
pathologies
Aleksandra Wojtala1, Magdalena Lebiedzinska1,
Agnieszka Karkucinska-Wieckowska2, Maciej Pronicki2,
Jerzy Duszynski1, Mariusz R. Wieckowski1
1Department of Biochemistry, Nencki Institute of Experimental Biology,
Warsaw, Poland
2Department of Pathology, Childrens'Memorial Heath Institute, Warsaw,
Poland
E-mail: aleksandra.wojtala@gmail.com
The growth factor adaptor protein, p66Shc, has a substantial
impact on mitochondrial metabolism through regulation of cellular
response to oxidative stress [1]. Low level of the p66Shc protein or its
complete ablation protects against numerous age-related disorders
and may partially prevent pathologies caused by reactive oxygen
species (ROS). On the other hand, high level of p66Shc has been
correlated with increased intracellular ROS production [2].
In our studies we have shown that both extracellular and intra-
cellular oxidative stresses can trigger phosphorylation of p66Shc at
Ser36 leading to increased ROS production. Fibroblasts derived from
patients with deﬁned variousmitochondrial disorders have been used
as a model of a self-propelling intracellular oxidative stress. Detailed
characterization of bioenergetic parameters and ROS production in
cells harboring mitochondrial defects showed that ﬁbroblasts from
patients demonstrate an increased ROS production compared to
control cells. We have also observed alterations in the antioxidant
defense system, decreased levels of electron transfer chain complexes
and attenuated oxidative chain activity of the patient cells. Observed
mitochondrial dysfunctions correlated with the increased status of
p66Shc phosphorylation at Ser36. In order to decrease the global and
p66Shc-related ROS generation in patient cells we tested a series of
chemical compounds demonstrating antioxidant capacities (with
different intracellular localization and speciﬁcity for different ROS
molecules) as well as kinase inhibitors (targeted against kinases
involved in the p66Shc phosphorylation at Ser36).
Alterations in the p66Shc phosphorylation pathways or adminis-
tration of mitochondrially targeted antioxidants seems to be a
promising way to stop the vicious circle of ROS induced p66Shc
phosphorylation‐related ROS production. This approach may open
new possibilities for pharmacological interventions that could
minimize the cellular effects of p66Shc phosphorylation in case of
pathological intracellular oxidative stress.
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Neoplasias uncouple anabolic glucose utilization from oxygen
availability to sustain unrestrained growth when oxygen and
nutrients are scarce, but the concomitant decrease in mitochondrial
respiration potentially exposes cancer cells to oxidative stress. We
report that the mitochondrial chaperone TRAP1, which is induced in
most tumor types, is required for neoplastic growth, and confers
Abstracts S125
